DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus

Maria Beatriz S. Freire, David J. Van Dijk, Arie Erman, Geoffrey Boner, James H. Warram, Andrzej S. Krolewski*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background. To determine the relationship between DNA polymorphisms in the angiotensin I converting enzyme (ACE) gene, serum ACE activity and the risk of diabetic nephropathy. Methods. A case-control study was carried out in a population of Jewish insulin-dependent diabetes mellitus (IDDM) patients. Cases (77 IDDM patients with diabetic nephropathy) and controls (89 IDDM patients with normoalbuminuria) were genotyped with PCR protocols for detecting two DNA polymorphisms in the ACE gene: one in intron 7 detected with the restriction enzyme PstI and the other in intron 16 identified as an insertion/deletion (I/D). Results. The risk of nephropathy was increased only in patients homozygous for the allele with the PstI site. These homozygotes had a nephropathy risk that was 2.3 times (95% C.I.: 1.2-4.5) that of the other genotypes. Furthermore, these individuals did not have elevated serum ACE activity. Conclusions. The results of this study are evidence that the risk of diabetic nephropathy in IDDM is influenced by genetic variability at the ACE locus, but the responsible variant is not the I/D polymorphism in intron 16. Our findings require further studies in other populations.

Original languageEnglish
Pages (from-to)2553-2558
Number of pages6
JournalNephrology Dialysis Transplantation
Volume13
Issue number10
DOIs
StatePublished - Oct 1998

Fingerprint

Dive into the research topics of 'DNA polymorphisms in the ACE gene, serum ACE activity and the risk of nephropathy in insulin-dependent diabetes mellitus'. Together they form a unique fingerprint.

Cite this